Question 1

What are the most cited papers from Biotec Pharmacon (Norway)?

Accepted Answer

The most cited paper from Biotec Pharmacon (Norway) is "The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood" (Charlotte Sissener Engstad, Rolf Einar Engstad, Jan-Ole Olsen et al., 2002), with 122 citations. Next come "The structure of uracil-DNA glycosylase from Atlantic cod (Gadus morhua) reveals cold-adaptation features" (66) and "Macrophage stimulating agent soluble yeast β‐1,3/1,6‐glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo‐controlled phase II study" (66).

Question 2

Which research topics does Biotec Pharmacon (Norway) publish most on?

Accepted Answer

By volume in 2022-now: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Pneumocystis jirovecii pneumonia detection and treatment.

Question 3

Which fields of science does Biotec Pharmacon (Norway) work in?

Accepted Answer

In all years, 57% of research at Biotec Pharmacon (Norway) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (35%), Medicine (28%), Agricultural and Biological Sciences (15%). It does 1.5× the world's share of Life Sciences.